Gyomor- és nyelőcsőrák: vizsgálatok itt: Kína
723 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- No phaseNot yet taking people in KínaProspective Assessment of Alignment Between Multimodal Artificial Intelligence and Multidisciplinary Team Decisions in Gastrointestinal Oncology
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 69
- Run by
- Shanghai Minimally Invasive Surgery Center
See details and how to joinNCT07746830 - No phaseTaking peopleRetrospective Analysis of Early Gastric Cancer Patients Based on Prospective Clinical Dataset
- Where
- Beijing
- Életkor
- 18 év to 90 év
- People
- 5000
- Run by
- Beijing Friendship Hospital
See details and how to joinNCT07747688 - No phaseTaking peopleSingle-port Robotic Radical Gastrectomy for Gastric Cancer
- Where
- Chongqing
- Életkor
- 18 év to 75 év
- People
- 20
- Run by
- Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
See details and how to joinNCT07237126 - 3. fázisTaking peopleSurgery vs. Radical Chemoradiotherapy for Esophageal SCC After Neoadjuvant Immunochemotherapy
- Where
- Zhengzhou
- Életkor
- 18 év to 75 év
- People
- 1044
- Run by
- Henan Cancer Hospital
See details and how to joinNCT07629817 - 2. fázisTaking peopleSystemic Application of Cadonilimab, LM-302, and S-1 Combined With Intraperitoneal Infusion of Paclitaxel for the Treatment of Claudin 18.2-positive Gastric Cancer With Peritoneal Metastasis
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 40
- Run by
- Ruijin Hospital
See details and how to joinNCT06519591 - 1/2. fázisTaking peopleA Phase Ib/II Study of ATG-022 Plus Pembrolizumab With/Without Chemotherapy in Participants With Claudin (CLDN) 18.2-positive, HER2-negative, Unresectable or Metastatic Gastric or Gastroesophageal Junction AdenocarcinomaUnresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
- Where
- Anyang, Beijing, Chengdu, Fuzhou, Hefei, Jinan, Langfang, Lanzhou, Nanchang, Nanjing, Qingdao, Shanghai, Shenyang, Shijiazhuang, Suzhou, Taiyuan, Tianjin, Wenzhou, Wuhan, Xiamen, Xi’an, Xinxiang, Xuzhou, Yinchuan, Zhengzhou
- Életkor
- 18 év and over
- People
- 132
- Run by
- Antengene Biologics Limited
See details and how to joinNCT07327229 - 2. fázisTaking peopleComparing ICI Followed By CCRT And CCRT Followed By Immunotherapy In Unresectable LA-ESCC
- Where
- Beijing, Chengdu, Shenyang, Taiyuan, Tianjin, Zhengzhou
- Életkor
- 18 év to 75 év
- People
- 120
- Run by
- Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT07733830 - No phaseTaking peopleFruquintinib and Albumin-paclitaxel Combined With or Without PD-1 Antibody in 2nd-line Treatment of G/GEJ Adenocarcinoma
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 60
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT06417892 - No phaseTaking peopleHelicobacter Pylori Infection Status and Pathological Features for Predicting Gastric Cancer Biological Behavior and Prognosis: A Real-World Observational Study
- Where
- Beijing
- Életkor
- 18 év to 80 év
- People
- 1500
- Run by
- Chinese PLA General Hospital
See details and how to joinNCT07724496 - 1. fázisTaking peopleAPG-2449 in Patients With Advanced Solid Tumors
- Where
- Beijing, Changsha, Fuzhou, Guangzhou, Hangzhou, Wuhan, Zhengzhou
- Életkor
- 18 év and over
- People
- 165
- Run by
- Ascentage Pharma Group Inc.
See details and how to joinNCT03917043 - 2. fázisTaking peopleSHR-1701 Combined With Chemotherapy for Gastric or Gastroesophageal Junction Adenocarcinoma With Peritoneal Metastasis
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 60
- Run by
- Ruijin Hospital
See details and how to joinNCT07384234 - 1. fázisTaking peopleA Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
- Where
- Beijing, Shanghai
- Életkor
- 18 év and over
- People
- 714 worldwide
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT05208762 · EU 2023-506604-18-00 - 1. fázisTaking peopleA Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
- Where
- Guangzhou, Jinan, Shanghai
- Életkor
- 18 év and over
- People
- 914 worldwide
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT06131840 · EU 2023-505858-18-00 - 2. fázisNot yet taking people in KínaEarly Response-guided Sequential Radiotherapy After Chemoimmunotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma
- Where
- Tianjin
- Életkor
- 18 év and over
- People
- 110
- Run by
- Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT07721103 - 2. fázisNot yet taking people in KínaNeoadjuvant SHR-A1811 and SHR-A1701 ± Pertuzumab for Potentially Immunotherapy-Sensitive GC or GEJ Adenocarcinoma
- Where
- Nanjing
- Életkor
- 18 év to 75 év
- People
- 24
- Run by
- The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT07716111 - 2. fázisTaking peopleA Dose Optimization/Expansion Study of SAR445877 in Adult Chinese Participants With Advanced Gastric or Gastroesophageal Junction Cancer
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 30
- Run by
- Sanofi
See details and how to joinNCT07692204 - 2. fázisTaking peopleSHR-1701 With or Without Apatinib in Combination With Chemotherapy as Neoadjuvant Therapy for Gastric Cancer
- Where
- Nanjing
- Életkor
- 18 év and over
- People
- 80
- Run by
- The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT07464756 - 2/3. fázisTaking peopleA Study of BL-B01D1 in Combination With Tislelizumab ±5-Fluorouracil Versus Platinum-Based Chemotherapy Plus Tislelizumab as First-line Treatment in Patients With Unresectable, Locally Advanced Recurrent or Metastatic Esophageal Squamous Cell Carcinoma(PANKU-Esophagus02)
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 90
- Run by
- Sichuan Baili Pharmaceutical Co., Ltd.
See details and how to joinNCT07554456 - Korai 1. fázisTaking peopleA Study to Evaluate the Human Biodistribution and Dosimetry of the Radionuclide Labeled IR199 in Patients With Gastric Cancer and Pancreatic Cancer
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 10
- Run by
- Huashan Hospital
See details and how to joinNCT07707531 - 2. fázisNot yet taking people in KínaAn Umbrella-designed Prospective Multicenter Randomized Open-label Superiority Trial Evaluating Multi-biomarker-guided Precision Therapy for First-line Treatment of Advanced Esophageal Squamous Cell Carcinoma
- Where
- Guangdong
- Életkor
- 18 év to 75 év
- People
- 347
- Run by
- Sun Yat-sen University
See details and how to joinNCT07709533 - 2. fázisNot yet taking people in KínaSacituzumab Tirumotecan (Sac-TMT/SKB264) Plus Tagitanlimab (KL-A167) in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma and Gastric/Gastroesophageal Junction Adenocarcinoma
- Where
- Guangzhou
- Életkor
- 18 év and over
- People
- 75
- Run by
- Sun Yat-sen University
See details and how to joinNCT07701681 - 2. fázisTaking peopleDocetaxel, Oxaliplatin and 5-FU for Gastric Cancer With Inoperable Malignant Bowel Obstruction
- Where
- Guangzhou
- Életkor
- 18 év to 75 év
- People
- 79
- Run by
- Sixth Affiliated Hospital, Sun Yat-sen University
See details and how to joinNCT04840264 - No phaseNot yet taking people in KínaCombination of CT and Ultrasound Radiomics Combined With Liquid Biopsy to Predict Neoadjuvant Chemotherapy Response in Patients With Locally Advanced Gastric Cancer
- Where
- Jinan
- Életkor
- 18 év to 80 év
- People
- 300
- Run by
- Liu Yang
See details and how to joinNCT07697079 - No phaseTaking peoplePD-1 Inhibitors Combined With Local Therapy at Different Timings in Oligometastatic ESCC
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 354
- Run by
- Fudan University
See details and how to joinNCT07697859 - 2. fázisTaking peopleNeoadjuvant Cardonilizumab Combined With Neoadjuvant Chemoradiotherapy Can Resect Locally Advanced Esophageal Squamous Cell Carcinoma
- Where
- Wuhan
- Életkor
- 18 év to 75 év
- People
- 336
- Run by
- Tongji Hospital
See details and how to joinNCT07699185